Das Universitätsklinikum Würzburg ist das Klinikum der Medizinischen Fakultät der Julius-Maximilians-Universität Würzburg und ein Krankenhaus der Maximalversorgung.

During the past decade, Universitätsklinikum Würzburg conducted 238 clinical trials. In the 10-year time frame, 238 clinical trials started and 69 clinical trials were completed, i.e. on average, 29% percent of trials that started reached the finish line to date. In the past 5 years, 114 clinical trials started and 51 clinical trials were completed. i.e. 44.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universitätsklinikum Würzburg" #1 sponsor was "Janssen Research & Development, LLC" with 17 trials, followed by "Celgene" with 16 trials sponsored, "Biotronik SE & Co. KG" with 12 trials sponsored, "Wuerzburg University Hospital" with 12 trials sponsored and "Boehringer Ingelheim" with 12 trials sponsored. Other sponsors include 249 different institutions and companies that sponsored additional 145 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsklinikum Würzburg" #1 collaborator was "Eli Lilly and Company" with 7 trials as a collaborator, "Wuerzburg University Hospital" with 5 trials as a collaborator, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 4 trials as a collaborator, "Boston Scientific Corporation" with 3 trials as a collaborator and "Deutsche Kinderkrebsstiftung" with 3 trials as a collaborator. Other collaborators include 243 different institutions and companies that were collaborators in the rest 216 trials.

According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Würzburg" are "Multiple Myeloma" (23 trials), "Heart Failure" (17 trials), "Acute Myeloid Leukemia" (9 trials), "Melanoma" (9 trials) and "Cystic Fibrosis" (7 trials). Many other conditions were trialed in "Universitätsklinikum Würzburg" in a lesser frequency.

Most popular intervention types in "Universitätsklinikum Würzburg" are "Drug" (207 trials), "Device" (51 trials), "Biological" (31 trials), "Other" (26 trials) and "Procedure" (14 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (49 trials), "Dexamethasone" (15 trials), "Daratumumab" (10 trials), "Cyclophosphamide" (8 trials) and "Lenalidomide" (8 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsklinikum Würzburg" are 312 trials for "All" genders, 5 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Universitätsklinikum Würzburg". undefined are not yet recruiting, 103 are recruiting, 57 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 120 completed trials in Universitätsklinikum Würzburg, 2 suspended trials, and 26 terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsklinikum Würzburg, 50 "Phase 1" clinical trials were conducted, 93 "Phase 2" clinical trials and 93 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 15 trials, and there were also 40 trials that are defined as “Not Applicable".

Universitätsklinikum Würzburg has several departments that took part in Clinical trials: "Department of Neurology, University of Wuerzburg" - 5 trials, "Dept. of Periodontology, University Hospital Wuerzburg" - 3 trials, "Universitätsklinikum Würzburg; Medizinische Klinik und Poliklinik II; Rheumatologie/Immunologie" - 2 trials, "Comprehensive Heart Failure Center, Universitätsklinikum Würzburg" - 2 trials, "Neurologische Klinik am Klinikum der BJM-Universität" - 2 trials, "Universitätskinderklinik Würzburg, Päd. Onkologie und Hämatologie" - 2 trials, "Universitätsklinikum Würzburg; Studienzentrale Hämatologie/Onkologie" - 2 trials, "Medizinische Klinik und Poliklinik I der Universität - Schwerpunkt Nephrologie" - 2 trials, "Dept. of Internal Medicine II, University of Wuerzburg" - 2 trials, "Clinical Trial Unit, Orthopedic Department, Wuerzburg University" - 2 trials